0
IBIO, Inc. Banner Image

IBIO, Inc. has reached its limit for free report views

Work for IBIO, Inc.? Upgrade Your Profile and unlock all your annual reports.

IBIO, Inc.

  • Ticker IBIO
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
IBIO, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. IBIO-CFB03, produced using the Company's proprietary gene expression technology, is the first product candidate from this program being advanced for IND development. The Company also offers proprietary products and productMore licenses to others based on its proprietary technologies, providing collaborators full support for turn-key implementation of its technology for protein therapeutics and vaccines.
IBIO, Inc.

Most Recent Annual Report

IBIO, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. IBIO, Inc. has reached its limit for free report views.

Older/Archived Annual Reports